decorative image
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
decorative image
The site is secure.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
seed logo
small business image

[Omnibus Solicitations] [Targeted Opportunities]

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. Read on to explore your options.

Helpful Tips

Omnibus Solicitations (Parent Announcements)

Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not target a specific topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations.

Read the Program Descriptions and Research Topics to understand the awarding components, their topics of interest, and staff contacts. For topics that require additional funding to reach the marketplace, please refer to our list of SBA approved waiver eligible topics.

Standard Application Due Dates: September 5, January 5, and April 5. Due dates that fall on weekends or Federal holidays move to the next business day.

Title Notice/FOA Number Organization Release Date Due Date(s) Expiration Date
PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-21-260 NIH 07/08/2021 Standard dates apply ...(see announcement for full details) 04/06/2022
PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-21-262 NIH 07/08/2021 Standard dates apply...(see announcement for full details) 04/06/2022
PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA-21-261 NIH 07/08/2021 Standard dates apply...(see announcement for full details) 04/06/2022
PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-21-259 NIH 07/08/2021 Standard dates apply ...(see announcement for full details) 04/06/2022

Targeted Funding Opportunities

Targeted SBIR/STTR grant solicitations are focused on specific research areas. Some targeted FOAs, identified as RFAs (Requests for Applications) or PASs (Program Announcements with Set-aside funds), have funding set-aside in the Institute/Center's budget for that targeted program.

Title Notice/FOA Number Organization Release Date Due Date(s) Expiration Date
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) PAS-19-317 NIANINDS 07/18/2019 Standard dates apply, by 5:00 PM local time of app...(see announcement for full details) 09/07/2022
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) PAS-19-316 NIANINDS 07/18/2019 Standard dates apply, by 5:00 PM local time of app...(see announcement for full details) 09/07/2022
Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed) RFA-DA-22-018 NIDA 07/29/2021 February 18, 2022 No late applications will be acc...(see announcement for full details) 02/19/2022
Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 - Clinical Trial Not Allowed) RFA-DA-22-023 NIDA 07/29/2021 February 18, 2022 No late applications will be acc...(see announcement for full details) 02/19/2022
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) PAR-21-057 NINDS 11/19/2020 February 22, 2021, June 22, 2021, February 22, 202...(see announcement for full details) 09/08/2023
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) RFA-TR-21-010 NCATS 01/13/2021 April 13, 2021, September 13, 2021, January 12, 20...(see announcement for full details) 01/13/2022
Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) PAR-21-282 NIDANIMHNEINIDCRNIAOBSSRNCCIHNIBIBNICHDNIAAANINDS 08/20/2021 October 20, 2021; February 18, 2022; June 20, 2022...(see announcement for full details) 06/21/2024
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-21-233 NINDSNIAAANIANCCIHNICHDNIBIBNIMHOBSSRNIDCRNIDANEI 04/23/2021 August 10, 2021, February 9, 2022, August 9, 2022,...(see announcement for full details) 04/06/2024
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-20-111 NINDSNCCIHNIDCRNIAAANICHDNIDANIANEIOBSSRNIMH 03/03/2020 August 11, 2020, February 9, 2021,August 10, 2021,...(see announcement for full details) 05/08/2023
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) PAR-21-059 NINDS 11/19/2020 March 15, 2021, June 22, 2021, February 22, 2022, ...(see announcement for full details) 09/08/2023
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed) PA-20-047 NIMHNCATSNCINEINHGRINIDANIDCRNIEHSNIGMS 01/07/2020 Standard dates apply, by 5:00 PM local time of app...(see announcement for full details) 01/06/2023
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed) PA-20-025 NIMHNIEHSNIGMSNCATSNIDCRNIDANEINHGRI 01/07/2020 Standard dates apply, by 5:00 PM local time of app...(see announcement for full details) 01/06/2023
Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed) PA-19-075 NIDCR 11/26/2018 Standard dates apply...(see announcement for full details) 01/06/2022
Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed) PA-19-076 NIDCR 11/26/2018 Standard dates apply...(see announcement for full details) 01/06/2022
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) RFA-NS-20-009 NINDSNICHDNIBIBNIMHNIDDKNIAAANCCIHORIPNIANIAMSNHLBINIGMSNCINIMHDNCATSNEININRNIDCRNLM 10/04/2019 January 8, 2020, April 7, 2020, September 9, 2020,...(see announcement for full details) 09/09/2022
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) RFA-NS-20-008 NINDSNCCIHNCINEINHLBINIANIAAANIAMSNIBIBNICHDNIDDKNIGMSNIMHNIMHDNINR 10/04/2019 January 8, 2020, April 7, 2020, September 9, 2020,...(see announcement for full details) 09/09/2022
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) RFA-NS-20-011 NINDSNIAAANIANIAMSNCCIHNCINIDDKNIGMSNICHDNIBIBNIMHDNLMNIMHNINRNCATSORIPNHLBINIDCRNEI 10/04/2019 January 8, 2020, April 7, 2020, September 9, 2020,...(see announcement for full details) 09/09/2022
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) RFA-NS-20-010 NINDSNCCIHNCINEINHLBINIANIAAANIAMSNIBIBNICHDNIDDKNIGMSNIMHNIMHDNINR 10/04/2019 January 8, 2020, April 7, 2020, September 9, 2020,...(see announcement for full details) 09/09/2022
IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) RFA-GM-22-001 NIGMS 10/07/2021 01/06/2022
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 Clinical Trial Not Allowed) PAR-20-244 NIGMS 06/25/2020 September 4, 2020; September 3, 2021; September 2 ...(see announcement for full details) 09/03/2022
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 Clinical Trial Not Allowed) PAR-20-239 NIGMS 06/25/2020 September 4, 2020; September 3, 2021; September 2,...(see announcement for full details) 09/03/2022
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) PAR-21-030 NIAMS 10/08/2020 Standard datesapply The first standard due date f...(see announcement for full details) 09/06/2022
Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed) PAR-21-298 NICHDNIMH 08/31/2021 Only accepting applications for the AIDS Applicati...(see announcement for full details) 12/10/2023
Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed) PAR-21-297 NICHDNIAIDNIMH 08/31/2021 Only accepting applications for the AIDS Applicati...(see announcement for full details) 12/10/2023
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) PAR-21-224 NINDS 05/05/2021 Standard dates apply *** Note new SBIR/STTR Standa...(see announcement for full details) 04/06/2024
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-23-009 NHLBI 11/16/2021 02/29/2024
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-23-008 NHLBINCATS 11/16/2021 02/29/2024
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) PAR-21-082 NIAID 01/14/2021 May 14, 2021; September 13, 2021; January 14, 2022...(see announcement for full details) 01/14/2024
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) PAR-21-267 NINDS 07/16/2021 Standard dates apply The first standard due date f...(see announcement for full details) 04/06/2024
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) PAR-21-266 NINDS 07/15/2021 Standard dates apply The first standard due date f...(see announcement for full details) 04/06/2024
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) PAR-21-265 NINDS 07/15/2021 Standard dates apply The first standard due date f...(see announcement for full details) 04/06/2024
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) PAR-21-114 NINDS 01/25/2021 Standard dates apply The first standard due date f...(see announcement for full details) 01/06/2024
Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed) PAR-20-109 NCATSNINDSNIANIGMSNIAID 02/06/2020 Standard dates apply The first standard due date f...(see announcement for full details) 01/06/2022
Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed) PAR-20-098 NCATSNIANIGMSNIAIDNINDS 02/06/2020 Standard dates apply The first standard due date f...(see announcement for full details) 01/06/2022
Notice of Special Interest (NOSI): Next-Generation Approaches to Renal Replacement Therapy Including Vascular Access NOT-DK-19-027 NIDDKNIBIBNCATS 10/09/2019 01/07/2023
Notice of Special Interest (NOSI) for the NEI Anterior Segment Initiative (ASI): Identification and Development of New Biomarkers and Effective methods to Diagnose Dry Eye Disease. NOT-EY-21-007 NEI 12/21/2020 05/08/2023
Notice of Special Interest (NOSI) of NIDCR in Supporting Dental, Oral, and Craniofacial Research Using Bioinformatic, Computational, and Data Science Approaches NOT-DE-20-006 NIDCR 06/05/2020 08/08/2023
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research NOT-AI-22-004 NIAIDNIAMSNCCIHNCI 11/23/2021 01/08/2025
Notice of Special Interest (NOSI): HIV Drug Resistance Assays and Actionable Data Dissemination Strategies NOT-AI-21-056 NIAIDNIDA 06/17/2021 05/08/2024
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics NOT-AI-20-013 NIAIDNIBIB 12/17/2019 01/08/2023
Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application NOT-HG-21-018 NHGRI 12/04/2020 01/10/2024
Notice of Special Interest (NOSI): Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42, R43/R44 Clinical Trial Not Allowed) NOT-DE-21-012 NIDCR 09/01/2021 09/05/2025
Notice of Special Interest (NOSI): Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (SBIR/STTR) NOT-AT-21-001 NCCIH 10/23/2020 01/05/2024
Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease NOT-HL-19-731 NHLBI 12/16/2019 01/08/2022
Notice of Special Interest (NOSI): Genomics Education Interactive Digital Media Resources (SBIR/STTR) NOT-HG-21-038 NHGRI 08/26/2021 12/31/2024
Notice of Special Interest (NOSI): Hearing Healthcare for Adults: Improving Access and Affordability NOT-DC-21-001 NIDCD 02/16/2021 01/08/2024
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets NOT-MH-20-024 NIMH 03/30/2020 05/08/2023
Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children NOT-DK-20-036 NIDDKNIBIB 07/23/2020 09/05/2022
Notice of Special Interest (NOSI): Improving Outcomes for Disorders of Human Communication NOT-DC-20-007 NIDCD 05/22/2020 01/10/2022
Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health NOT-OD-21-100 OBSSRNIMHDNIDANIMHORWHNIDCDSGMROODPNIANHLBINCININRNCCIHNEINICHD 04/08/2021 06/08/2024
Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment NOT-MH-20-013 NIMH 03/30/2020 05/08/2023
Notice of Special Interest (NOSI): Methods Development in Natural Products Research (SBIR/STTR) NOT-AT-20-015 NCCIH 07/16/2020 09/06/2023
Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings NOT-CA-21-062 NCI 07/23/2021 09/07/2024
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition NOT-HD-21-027 NICHDNIAAANCINIMHNIAMSOBSSRNIBIBNIDCR 06/22/2021 01/08/2024
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders NOT-DC-20-008 NIDCD 06/04/2020 09/08/2022
Notice of Special Interest (NOSI): Research in the Emergency Setting NOT-NS-20-005 NINDSNCINIDANHLBINIDCDNIAAANICHDNIANIGMSNEINIMHDNIMH 09/08/2020 09/08/2022
Notice of Special Interest (NOSI): Research on Strategies to Enhance Mental Health Interventions and Services within Employment and Job Training Settings NOT-MH-21-230 NIMHNIDA 04/16/2021 09/08/2023
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health NOT-EB-21-001 NIBIBNIAIDORWHNICHDNIMHDNIMHNINDSODNCATSNHLBINHGRI 02/22/2021 04/06/2023
Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum NOT-MH-20-023 NIMH 03/30/2020 05/08/2023
Notice of Special Interest (NOSI): Strengthening the HIV Prevention Continuum NOT-MH-20-019 NIMH 03/27/2020 05/08/2023
Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace NOT-MH-21-125 NIMHNIANIAAANIBIBNINDSNIDANEINCCIHNICHDNIDCD 03/03/2021 01/06/2024
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes NOT-CA-21-031 NCINIA 01/27/2021 01/08/2024
Notice of Special Interest: Advancing Research for Tickborne Diseases (TBDs) NOT-AI-20-005 NIAIDNCCIHNIAMSNIMHNINDS 11/12/2019 01/08/2023
Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders NOT-NS-22-010 NINDS 10/01/2021 01/08/2025
Notice of Special Interest: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications NOT-DK-20-001 NIDDK 11/01/2019 01/08/2023
Notice of Special Interest: Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults NOT-MH-20-035 NIMH 04/01/2020 05/08/2023
Notice of Special Interest: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44) NOT-HD-20-025 NICHD 09/11/2020 01/08/2022
Notice of Special Interest: Kidney Precision Medicine Technology Development and Translation NOT-DK-21-007 NIDDK 12/02/2020 09/06/2023
Notice of Special Interest: NIDCD Health Disparities and Inequities Research NOT-DC-21-003 NIDCDSGMRO 06/11/2021 05/08/2024
Notice of Special Interest: NIGMS Priorities for Small Business Development of Sepsis Diagnostics and Therapeutics NOT-GM-20-028 NIGMS 06/02/2020 09/12/2023
Notice of Special Interest: Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed) NOT-OD-20-085 ORIP 03/26/2020 01/06/2022
Notice of Special Interest: Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed) NOT-OD-20-084 ORIP 03/26/2020 01/06/2022
Notice of Special Interest: SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) NOT-NS-22-017 NINDSNIDCRNEINCINIA 11/12/2021 01/08/2025
Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones NOT-DK-20-002 NIDDK 11/06/2019 01/08/2023
Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment NOT-MH-20-020 NIMH 03/30/2020 05/08/2023
Notice of Special Interest: Understanding the Biology of Iodine Nutrition, Assessment, and Outcomes (R01, R21, R03, R43/R44, R41/R42) NOT-HD-19-039 NICHDODS 12/02/2019 01/08/2022
Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed) RFA-HG-20-016 NHGRINCATS 03/19/2020 June 24, 2020; March 9, 2021; February 4, 2022 Al...(see announcement for full details) 02/05/2022
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed) PAR-21-226 ORIP 04/30/2021 Standard dates apply The first standard due date f...(see announcement for full details) 09/06/2024
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed) PAR-21-225 ORIP 04/30/2021 Standard dates apply The first standard due date f...(see announcement for full details) 09/06/2024
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) PAR-20-128 NIHNIAMSNIDCRNIBIBNIMHNIDCDNIGMSNIDDKNIEHSNCATSNLMNCCIHNEINHGRINIAAANHLBINCINIA 07/10/2020 All applications are due by 5:00 PM local time of ...(see announcement for full details) 04/06/2022
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) PAR-20-130 NIHNIDCDNINDSNIMHNIANEINHLBINICHDNIAAA 07/10/2020 Standard dates apply All applications are due by ...(see announcement for full details) 04/06/2022
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) PAR-20-129 NIHNIAMSNIDCDNIDCRNEINIAIDNIGMSNIDDKNIMHNINDSNIAAANHLBINICHDNIA 07/10/2020 Standard dates apply All applications are due by ...(see announcement for full details) 04/06/2022
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) RFA-MH-21-112 NIMH 11/13/2020 ?February 18, 2021; October 15, 2021, June 15, 202...(see announcement for full details) 06/16/2022
Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) RFA-DK-21-021 NIDDKNIAID 06/25/2021 February 17, 2022 and October 7, 2022 ...(see announcement for full details) 10/08/2022
Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed) RFA-DK-21-011 NIDDK 05/06/2021 March 9, 2022 and October 7, 2022 ...(see announcement for full details) 10/08/2022
Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) RFA-DK-21-012 NIDDK 05/19/2021 March 9, 2022 and October 7, 2022 ...(see announcement for full details) 10/08/2022
Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) PAR-21-247 NHGRINIAIDNCI 07/12/2021 October 1, 2021; June 15, 2022; June 15, 2023 All...(see announcement for full details) 06/16/2023
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) RFA-HG-21-008 NHGRI 03/30/2021 June 25, 2021; March 1, 2022; February 1, 2023 Al...(see announcement for full details) 02/02/2023
Translational Neural Devices (U44 Clinical Trial Optional) RFA-NS-21-022 NINDS 04/28/2021 July 1, 2021; October 20, 2021; February 18, 2022;...(see announcement for full details) 02/21/2024